Chinese buyout giant CDH Investments has reportedly launched its sixth China fund.
The vehicle is targeting up to $2.5bn, but is yet to set a hard cap, according to AVCJ.
If it hits its target it would equal its predecessor, which collected the same amount in 2014, but comfortably beat its $1.45bn 2010 vehicle.
The strategy the vehicle will adopt has not been confirmed, but the firm typically targets leading Chinese brands in the consumer, industrial, services, medical, financial and energy sectors.
The firm also runs mezzanine, venture capital strategy, real estate and wealth management arms.
Its current private equity portfolio is made up of 70 companies across China, including medication service provider IPharmaCare and medical imaging company AllTech.
CDH’s first China-focused private equity fund was raised in 2002 and collected $102m. Since then it has raised six funds, including a $1.6bn China growth capital fund in 2008.
Most recently it led a private equity funding round in consumer goods business SharkNinja.
A month before, it led a $300m series B round in online logistics platform company Yimidida.
Copyright © 2017 AltAssets